BACKGROUND: The stigma associated with neurologic disorders plays a part in poor health-related quality of life. The eight-item Stigma Scale for Chronic Illness (SSCI-8) is a brief self-assessment tool for measuring perceived level of stigma. The psychometric performance of the SSCI-8 in people with multiple sclerosis (MS) was assessed. METHODS: A multicenter, cross-sectional study in adults with relapsing-remitting or primary progressive MS was performed. A nonparametric item response theory procedure, Mokken analysis, was done to preliminarily study the dimensional structure of the SSCI-8. A confirmatory factor analysis (CFA) model was then fit, and the behavior and information covered by the eight items were assessed by parametric item response theory analysis. RESULTS: A total of 201 patients (mean ± SD age, 43.9 ± 10.5 years; 60.2% female; 86.1% with relapsing-remitting MS) were studied. The Mokken analysis found that the SSCI-8 is a unidimensional strong scale (scalability index H = 0.56) with high reliability (Cronbach α = 0.88). The CFA model confirmed the unidimensionality (comparative fit index = 0.975, root mean square error of approximation = 0.077). The information covered by the SSCI-8 items ranges from 3.79 to 13.52, for a total of 66.56. More than half (66%) of the SSCI-8 overall information is conveyed by four items: 1 ("Some people avoided me"), 2 ("I felt left out of things"), 3 ("People avoided looking at me"), and 7 ("People were unkind to me"). CONCLUSIONS: The SSCI-8 shows appropriate psychometric characteristics and is, therefore, a useful instrument for assessing stigma in people with MS.
BACKGROUND: The stigma associated with neurologic disorders plays a part in poor health-related quality of life. The eight-item Stigma Scale for Chronic Illness (SSCI-8) is a brief self-assessment tool for measuring perceived level of stigma. The psychometric performance of the SSCI-8 in people with multiple sclerosis (MS) was assessed. METHODS: A multicenter, cross-sectional study in adults with relapsing-remitting or primary progressive MS was performed. A nonparametric item response theory procedure, Mokken analysis, was done to preliminarily study the dimensional structure of the SSCI-8. A confirmatory factor analysis (CFA) model was then fit, and the behavior and information covered by the eight items were assessed by parametric item response theory analysis. RESULTS: A total of 201 patients (mean ± SD age, 43.9 ± 10.5 years; 60.2% female; 86.1% with relapsing-remitting MS) were studied. The Mokken analysis found that the SSCI-8 is a unidimensional strong scale (scalability index H = 0.56) with high reliability (Cronbach α = 0.88). The CFA model confirmed the unidimensionality (comparative fit index = 0.975, root mean square error of approximation = 0.077). The information covered by the SSCI-8 items ranges from 3.79 to 13.52, for a total of 66.56. More than half (66%) of the SSCI-8 overall information is conveyed by four items: 1 ("Some people avoided me"), 2 ("I felt left out of things"), 3 ("People avoided looking at me"), and 7 ("People were unkind to me"). CONCLUSIONS: The SSCI-8 shows appropriate psychometric characteristics and is, therefore, a useful instrument for assessing stigma in people with MS.
Authors: Deepa Rao; Seung W Choi; David Victorson; Rita Bode; Amy Peterman; Allen Heinemann; David Cella Journal: Qual Life Res Date: 2009-04-25 Impact factor: 4.147
Authors: Peter Rieckmann; Diego Centonze; Irina Elovaara; Gavin Giovannoni; Eva Havrdová; Jurg Kesselring; Gisela Kobelt; Dawn Langdon; Sarah A Morrow; Celia Oreja-Guevara; Sven Schippling; Christoph Thalheim; Heidi Thompson; Patrick Vermersch; Karen Aston; Birgit Bauer; Christy Demory; Maria Paz Giambastiani; Jana Hlavacova; Jocelyne Nouvet-Gire; George Pepper; Maija Pontaga; Emma Rogan; Chrystal Rogalski; Pieter van Galen; Ali-Frédéric Ben-Amor Journal: Mult Scler Relat Disord Date: 2017-11-21 Impact factor: 4.339
Authors: Chris H Polman; Stephen C Reingold; Brenda Banwell; Michel Clanet; Jeffrey A Cohen; Massimo Filippi; Kazuo Fujihara; Eva Havrdova; Michael Hutchinson; Ludwig Kappos; Fred D Lublin; Xavier Montalban; Paul O'Connor; Magnhild Sandberg-Wollheim; Alan J Thompson; Emmanuelle Waubant; Brian Weinshenker; Jerry S Wolinsky Journal: Ann Neurol Date: 2011-02 Impact factor: 10.422
Authors: Francisco Pérez-Miralles; Daniel Prefasi; Antonio García-Merino; José R Ara; Guillermo Izquierdo; Virginia Meca-Lallana; Francisco Gascón; María L Martínez-Ginés; Lluis Ramió-Torrentà; Lucienne Costa-Frossard; Óscar Fernández; Sara Moreno-García; Jorge Maurino; Bonaventura Casanova-Estruch Journal: Mult Scler J Exp Transl Clin Date: 2019-05-22
Authors: Jose E Meca-Lallana; Daniel Prefasi; Francisco Pérez-Miralles; Lucía Forero; María Sepúlveda; Carmen Calles; María L Martínez-Ginés; Inés González-Suárez; Sabas Boyero; Lucía Romero-Pinel; Ángel P Sempere; Virginia Meca-Lallana; Luis Querol; Lucienne Costa-Frossard; Hugo de Castro-Trapiello; Neus Canal; Jorge Maurino Journal: Patient Prefer Adherence Date: 2021-04-12 Impact factor: 2.711
Authors: Richard Brown; Lynne Coventry; Elizabeth Sillence; John Blythe; Simone Stumpf; Jon Bird; Abigail C Durrant Journal: Digit Health Date: 2022-03-07
Authors: José E Meca-Lallana; Rocío Gómez-Ballesteros; Francisco Pérez-Miralles; Lucía Forero; María Sepúlveda; Carmen Calles; María L Martínez-Ginés; Inés González-Suárez; Sabas Boyero; Lucía Romero-Pinel; Ángel P Sempere; Virginia Meca-Lallana; Luis Querol; Lucienne Costa-Frossard; Daniel Prefasi; Jorge Maurino Journal: Neurol Ther Date: 2022-05-06